Zeidán-Chuliá Fares, Noda Mami
Medical Biochemistry and Developmental Biology, Institute of Biomedicine, University of Helsinki, Finland.
Eur J Dent. 2009 Jul;3(3):240-9.
Adult mesenchymal stem cells (MSCs) are adherent stromal cells able to self-renew and differentiate into a wide variety of cells and tissues. MSCs can be obtained from distinct tissue sources and have turned out to be successfully manipulated in vitro. As adult stem cells, MSCs are less tumorigenic than their embryonic correlatives and posses another unique characteristic which is their almost null immunogenicity. Moreover, these cells seem to be immunosuppressive in vitro. These facts together with others became MSCs a promising subject of study for future approaches in bioengineering and cell-based therapy. On the other hand, new strategies to achieve long-term integration as well as efficient differentiation of these cells at the area of the lesion are still challenging, and the signalling pathways ruling these processes are not completely well characterized. In this review, we are going summarize the general landscape and current status of the MSC tool as well as their wide potential in tissue engineering, from neuronal to tooth replacement. Highlights and pitfalls for further clinical applications will be discussed.
成人间充质干细胞(MSCs)是一种贴壁基质细胞,能够自我更新并分化为多种细胞和组织。MSCs可以从不同的组织来源获得,并且已证明在体外可以成功进行操作。作为成体干细胞,MSCs的致瘤性低于其胚胎对应物,并且具有另一个独特的特征,即几乎没有免疫原性。此外,这些细胞在体外似乎具有免疫抑制作用。这些事实以及其他因素使MSCs成为生物工程和基于细胞治疗未来方法的一个有前途的研究对象。另一方面,在损伤部位实现这些细胞的长期整合以及有效分化的新策略仍然具有挑战性,并且调控这些过程的信号通路尚未完全明确。在这篇综述中,我们将总结MSCs工具的总体情况和现状,以及它们在从神经组织修复到牙齿替换等组织工程中的广泛潜力。还将讨论进一步临床应用的重点和陷阱。